Document Detail

Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists.
MedLine Citation:
PMID:  21789157     Owner:  NLM     Status:  PubMed-not-MEDLINE    
It has been estimated that up to 3.8% of breast cancers may be diagnosed in women who are pregnant, with an estimated 1 in 3000-3500 deliveries occurring in women with breast cancer. Owing to the lack of large randomized trials available to guide our clinical practice, our decisions regarding adjuvant systemic management are based on retrospective analyses, case reports and a small number of prospective studies. A tailored approach to treatment is required with careful consideration given at all stages to the needs of the mother and risks to the foetus. Management is critically influenced by the stage of pregnancy, especially the first trimester. Anthracycline-based chemotherapy may be administered during the second and third trimesters, with apparently few short-term implications. Limited data shows the taxanes may also be given with few adverse events at these stages. Weekly fractionation regimens may allow closer monitoring of pregnancy with prompt termination of agents, if necessary. Data concerning the long-term risks of systemic anticancer treatment are limited. All stages of patient management should be discussed within a multidisciplinary team and a clear consensus of treatment options communicated to the mother. Delaying chemotherapy until after delivery may be reasonable in some cases, but where the delay is likely to be prolonged, a decision must be made on the basis of risks versus benefits.
Sophie E McGrath; Alistair Ring
Related Documents :
24695557 - Egfr signaling promotes β-cell proliferation and survivin expression during pregnancy.
25276527 - Achieving better maternal and newborn outcomes: coherent strategy and pragmatic, tailor...
22052087 - Transport of nanoparticles through the placental barrier.
21918727 - Do thyroid disrupting chemicals influence foetal development during pregnancy?
3581867 - Incorporation of 14c-galactose into gangliosides of rabbit lens.
18605967 - Anxiety symptoms during late pregnancy and early parenthood following assisted reproduc...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Therapeutic advances in medical oncology     Volume:  3     ISSN:  1758-8359     ISO Abbreviation:  Ther Adv Med Oncol     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-07-26     Completed Date:  2011-11-10     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101510808     Medline TA:  Ther Adv Med Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  73-83     Citation Subset:  -    
Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Health-related quality of life and cancer clinical trials.
Next Document:  Bevacizumab in metastatic breast cancer: when may it be used?